| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | CEBPE ESR1 TBX21 SOX18 NR4A1 AR HOXA1 HOXA10 LHX2 HOXB3 HOXD3 NFATC2 EGR1 GLI1 GLI2 FOXD1 | 1.96e-07 | 560 | 118 | 16 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | CEBPE ESR1 TBX21 SOX18 NR4A1 AR HOXA1 HOXA10 LHX2 HOXB3 HOXD3 NFATC2 EGR1 GLI1 GLI2 FOXD1 | 2.27e-07 | 566 | 118 | 16 | GO:0001216 |
| GeneOntologyMolecularFunction | transcription factor binding | ZNF703 ESR1 PER1 PPP1R13B DAZAP2 NR4A1 ARID1A CREG1 AR LHX2 NFATC2 CTBP1 NR3C2 NR5A1 FKBP4 RBFOX2 CRTC2 | 2.09e-06 | 753 | 118 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | CEBPE ESR1 TBX21 PER1 SOX18 NR4A1 AR HOXA1 HOXA10 LHX2 HOXB3 HOXD3 NFATC2 EGR1 GLI1 GLI2 BHLHE22 ZFHX3 NR3C2 NR5A1 HOXB13 FOXD1 | 3.31e-06 | 1244 | 118 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | CEBPE ESR1 TBX21 PER1 SOX18 NR4A1 AR HOXA1 HOXA10 LHX2 HOXB3 HOXD3 NFATC2 EGR1 GLI1 GLI2 BHLHE22 ZFHX3 NR3C2 NR5A1 HOXB13 FOXD1 | 4.68e-06 | 1271 | 118 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | chromatin binding | ESR1 PER1 WBP2NL ARID1A AR CIC LHX2 NFATC2 EGR1 GLI1 GLI2 BHLHE22 CTBP1 NR5A1 AJUBA CRTC2 | 7.27e-06 | 739 | 118 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | CEBPE ESR1 TBX21 SOX18 NR4A1 AR CIC HOXA1 HOXA10 LHX2 HOXB3 HOXC12 HOXD3 NFATC2 EGR1 GLI1 GLI2 BHLHE22 ZFHX3 NR3C2 NR5A1 HOXB13 FOXD1 | 7.49e-06 | 1412 | 118 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | CEBPE ESR1 TBX21 PER1 SOX18 NR4A1 AR CIC HOXA1 HOXA10 LHX2 HOXB3 HOXD3 NFATC2 EGR1 GLI1 GLI2 BHLHE22 ZFHX3 NR3C2 NR5A1 HOXB13 FOXD1 | 1.27e-05 | 1459 | 118 | 23 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.79e-05 | 60 | 118 | 5 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 3.02e-05 | 61 | 118 | 5 | GO:0098531 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 3.21e-05 | 11 | 118 | 3 | GO:0034056 | |
| GeneOntologyMolecularFunction | zinc ion binding | NAALADL1 FNTB ESR1 ADAMTS13 NR4A1 AR SEC24D SEC24C PIAS3 EGR1 DPF3 GLI2 ZFHX3 NR3C2 NR5A1 MMP15 | 7.06e-05 | 891 | 118 | 16 | GO:0008270 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.85e-04 | 140 | 118 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | transition metal ion binding | NAALADL1 FNTB ESR1 ADAMTS13 NR4A1 AR SEC24D SEC24C PIAS3 EGR1 DPF3 GLI2 ZFHX3 NR3C2 NR5A1 MMP15 MOCOS | 6.16e-04 | 1189 | 118 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | ZNF703 ESR1 PER1 DAZAP2 NR4A1 ARID1A AR CTBP1 FKBP4 RBFOX2 CRTC2 | 6.72e-04 | 582 | 118 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | lipid binding | PLEKHB2 ABCA4 CEACAM5 ESR1 ANXA7 INSR TNS2 STAM NR4A1 AR FZD7 ARAP3 HGS NR3C2 NR5A1 | 7.20e-04 | 988 | 118 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | O-acetyltransferase activity | 1.21e-03 | 9 | 118 | 2 | GO:0016413 | |
| GeneOntologyMolecularFunction | microtubule severing ATPase activity | 1.21e-03 | 9 | 118 | 2 | GO:0008568 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 2.09e-03 | 43 | 118 | 3 | GO:0004177 | |
| GeneOntologyBiologicalProcess | prostate gland development | 5.32e-08 | 62 | 115 | 7 | GO:0030850 | |
| GeneOntologyBiologicalProcess | urogenital system development | 2.90e-07 | 79 | 115 | 7 | GO:0001655 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CEBPE ESR1 TBX21 PER1 SOX18 SSBP2 NR4A1 AR HOXA1 HOXA10 LHX2 HOXB3 HOXD3 NFATC2 EGR1 GLI1 GLI2 BHLHE22 ZFHX3 NR3C2 NR5A1 FOXD1 CRTC2 | 2.13e-06 | 1390 | 115 | 23 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF703 ESR1 TBX21 PER1 SOX18 ARID1A CREG1 MIDEAS AR CIC HOXB3 PIAS3 ZNF608 NFATC2 EGR1 GLI2 BHLHE22 CTBP1 ZFHX3 AJUBA HOXB13 RBFOX2 FOXD1 | 2.38e-06 | 1399 | 115 | 23 | GO:0045892 |
| GeneOntologyBiologicalProcess | gland development | ZNF703 CEACAM5 ESR1 INSR AR HOXA10 HOXB3 HOXD3 GLI1 GLI2 NR5A1 CSMD1 FKBP4 HOXB13 | 2.78e-06 | 558 | 115 | 14 | GO:0048732 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF703 ESR1 TBX21 PER1 SOX18 ARID1A CREG1 MIDEAS AR CIC HOXB3 PIAS3 ZNF608 NFATC2 EGR1 GLI2 BHLHE22 CTBP1 ZFHX3 AJUBA HOXB13 RBFOX2 FOXD1 | 2.81e-06 | 1413 | 115 | 23 | GO:1902679 |
| GeneOntologyBiologicalProcess | mammary gland branching involved in pregnancy | 5.81e-06 | 7 | 115 | 3 | GO:0060745 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.12e-05 | 136 | 115 | 7 | GO:0030518 | |
| GeneOntologyBiologicalProcess | regionalization | SOX18 AR HOXA1 HOXA10 LHX2 HOXB3 HOXD3 GLI1 GLI2 BHLHE22 FOXD1 DNAH11 | 1.49e-05 | 478 | 115 | 12 | GO:0003002 |
| GeneOntologyBiologicalProcess | male sex differentiation | 1.60e-05 | 199 | 115 | 8 | GO:0046661 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 2.63e-05 | 155 | 115 | 7 | GO:0043401 | |
| GeneOntologyBiologicalProcess | notochord regression | 3.08e-05 | 2 | 115 | 2 | GO:0060032 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 3.31e-05 | 33 | 115 | 4 | GO:0060740 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 3.74e-05 | 34 | 115 | 4 | GO:0060512 | |
| GeneOntologyBiologicalProcess | pattern specification process | SOX18 AR HOXA1 HOXA10 LHX2 HOXB3 HOXD3 GLI1 GLI2 BHLHE22 FOXD1 DNAH11 | 3.80e-05 | 526 | 115 | 12 | GO:0007389 |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 5.10e-05 | 172 | 115 | 7 | GO:0046546 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 5.72e-05 | 383 | 115 | 10 | GO:0048608 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 6.34e-05 | 178 | 115 | 7 | GO:0022612 | |
| GeneOntologyBiologicalProcess | reproductive system development | 6.38e-05 | 388 | 115 | 10 | GO:0061458 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.81e-05 | 244 | 115 | 8 | GO:0009755 | |
| GeneOntologyBiologicalProcess | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 7.32e-05 | 15 | 115 | 3 | GO:0043328 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ESR1 TBX21 PER1 SOX18 ARID1A AR CIC HOXB3 PIAS3 ZNF608 NFATC2 EGR1 GLI2 CTBP1 ZFHX3 AJUBA HOXB13 | 7.37e-05 | 1053 | 115 | 17 | GO:0000122 |
| GeneOntologyBiologicalProcess | male sex determination | 8.97e-05 | 16 | 115 | 3 | GO:0030238 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 1.07e-04 | 84 | 115 | 5 | GO:0061180 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 1.07e-04 | 84 | 115 | 5 | GO:0006518 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 1.15e-04 | 45 | 115 | 4 | GO:0060603 | |
| GeneOntologyBiologicalProcess | cognition | 1.30e-04 | 423 | 115 | 10 | GO:0050890 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.40e-04 | 202 | 115 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | glossopharyngeal nerve morphogenesis | 1.84e-04 | 4 | 115 | 2 | GO:0021615 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | ZNF703 FNTB ESR1 ANXA7 PER1 ARID1A AR HOXA10 DUOX1 EGR1 GLI2 NR3C2 MMP15 FKBP4 HOXB13 RBFOX2 | 2.31e-04 | 1048 | 115 | 16 | GO:0014070 |
| GeneOntologyBiologicalProcess | endocrine system development | 2.88e-04 | 161 | 115 | 6 | GO:0035270 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 2.88e-04 | 57 | 115 | 4 | GO:0030520 | |
| GeneOntologyBiologicalProcess | glossopharyngeal nerve development | 3.05e-04 | 5 | 115 | 2 | GO:0021563 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 3.89e-04 | 239 | 115 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | male gonad development | 3.97e-04 | 171 | 115 | 6 | GO:0008584 | |
| GeneOntologyBiologicalProcess | behavior | CEACAM5 INSR CHAT FIGN AR CIC HOXA1 NLGN3 EGR1 ZFHX3 CSMD1 PRRT1 MYO15A DNAH11 | 4.40e-04 | 891 | 115 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 4.48e-04 | 27 | 115 | 3 | GO:0032511 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 4.56e-04 | 6 | 115 | 2 | GO:0090367 | |
| GeneOntologyBiologicalProcess | rhythmic synaptic transmission | 4.56e-04 | 6 | 115 | 2 | GO:0060024 | |
| GeneOntologyBiologicalProcess | ventral midline development | 4.56e-04 | 6 | 115 | 2 | GO:0007418 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 4.78e-04 | 65 | 115 | 4 | GO:0060443 | |
| GeneOntologyBiologicalProcess | response to lipid | ZNF703 CEBPE ESR1 PER1 ADAMTS13 NR4A1 ARID1A AR HOXA1 FZD7 HOXA10 NR3C2 MMP15 FKBP4 HOXB13 RBFOX2 | 5.12e-04 | 1126 | 115 | 16 | GO:0033993 |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 5.42e-04 | 416 | 115 | 9 | GO:0030522 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 5.55e-04 | 29 | 115 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | branching involved in mammary gland duct morphogenesis | 6.14e-04 | 30 | 115 | 3 | GO:0060444 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 6.14e-04 | 258 | 115 | 7 | GO:0001763 | |
| GeneOntologyBiologicalProcess | cell fate specification | 6.32e-04 | 123 | 115 | 5 | GO:0001708 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SOX18 ARID1A AR HOXA1 FZD7 HOXA10 LHX2 HOXB3 HOXD3 GLI1 GLI2 MYO15A | 6.33e-04 | 713 | 115 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | prostate glandular acinus morphogenesis | 6.35e-04 | 7 | 115 | 2 | GO:0060526 | |
| GeneOntologyBiologicalProcess | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 6.35e-04 | 7 | 115 | 2 | GO:0060527 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 6.35e-04 | 7 | 115 | 2 | GO:0090365 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | CEACAM5 ESR1 INSR SOX18 ARID1A AR HOXA1 HOXB3 HOXD3 GLI1 GLI2 BHLHE22 CSMD1 MYO15A HOXB13 FOXD1 DNAH11 | 6.60e-04 | 1269 | 115 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | sex determination | 6.77e-04 | 31 | 115 | 3 | GO:0007530 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | ESR1 FIGNL2 SOX18 ARID1A AR LHX2 GLI2 CSMD1 AJUBA HOXB13 FOXD1 | 6.89e-04 | 619 | 115 | 11 | GO:0002009 |
| GeneOntologyBiologicalProcess | cranial nerve morphogenesis | 7.44e-04 | 32 | 115 | 3 | GO:0021602 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | CEACAM5 ESR1 INSR PER1 TNS2 NR4A1 ARID1A AR NR3C2 NR5A1 FKBP4 RBFOX2 | 7.51e-04 | 727 | 115 | 12 | GO:0032870 |
| GeneOntologyBiologicalProcess | rhythmic behavior | 7.81e-04 | 74 | 115 | 4 | GO:0007622 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 7.92e-04 | 351 | 115 | 8 | GO:0048562 | |
| GeneOntologyBiologicalProcess | sex differentiation | 8.06e-04 | 352 | 115 | 8 | GO:0007548 | |
| GeneOntologyBiologicalProcess | multivesicular body assembly | 8.15e-04 | 33 | 115 | 3 | GO:0036258 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 8.22e-04 | 75 | 115 | 4 | GO:0032922 | |
| GeneOntologyBiologicalProcess | multivesicular body organization | 8.91e-04 | 34 | 115 | 3 | GO:0036257 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 8.91e-04 | 34 | 115 | 3 | GO:0043043 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | ZNF703 CEBPE ESR1 PER1 ADAMTS13 ARID1A AR HOXA1 FZD7 NR3C2 FKBP4 RBFOX2 | 9.61e-04 | 748 | 115 | 12 | GO:0071396 |
| GeneOntologyBiologicalProcess | regulation of female gonad development | 1.08e-03 | 9 | 115 | 2 | GO:2000194 | |
| GeneOntologyBiologicalProcess | rhombomere development | 1.08e-03 | 9 | 115 | 2 | GO:0021546 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.14e-03 | 37 | 115 | 3 | GO:0043162 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 1.14e-03 | 37 | 115 | 3 | GO:0009954 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.17e-03 | 373 | 115 | 8 | GO:0007611 | |
| GeneOntologyBiologicalProcess | development of primary female sexual characteristics | 1.21e-03 | 142 | 115 | 5 | GO:0046545 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport | 1.33e-03 | 39 | 115 | 3 | GO:0045324 | |
| GeneOntologyBiologicalProcess | prostatic bud formation | 1.35e-03 | 10 | 115 | 2 | GO:0060513 | |
| GeneOntologyCellularComponent | chromatin | DPF1 CEBPE ESR1 TBX21 SOX18 NR4A1 ARID1A AR CIC HOXA1 HOXA10 LHX2 HOXB3 HOXD3 PIAS3 NFATC2 EGR1 DPF3 BHLHE22 ZFHX3 NR3C2 NR5A1 HOXB13 FOXD1 | 2.24e-06 | 1480 | 118 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | CEBPE ESR1 SOX18 DAZAP2 NR4A1 CREG1 MIDEAS HOXA10 NFATC2 CTBP1 ZFHX3 NR5A1 AJUBA HOXB13 | 6.89e-06 | 596 | 118 | 14 | GO:0005667 |
| GeneOntologyCellularComponent | COPII vesicle coat | 9.31e-05 | 16 | 118 | 3 | GO:0030127 | |
| GeneOntologyCellularComponent | nBAF complex | 9.31e-05 | 16 | 118 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | ESCRT-0 complex | 9.44e-05 | 3 | 118 | 2 | GO:0033565 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 1.88e-04 | 4 | 118 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | vesicle coat | 5.62e-04 | 67 | 118 | 4 | GO:0030120 | |
| GeneOntologyCellularComponent | ESCRT complex | 7.72e-04 | 32 | 118 | 3 | GO:0036452 | |
| MousePheno | small prostate gland anterior lobe | 1.01e-05 | 7 | 94 | 3 | MP:0000664 | |
| MousePheno | increased circulating testosterone level | 2.56e-05 | 26 | 94 | 4 | MP:0002781 | |
| MousePheno | abnormal perineum morphology | 2.99e-05 | 27 | 94 | 4 | MP:0003315 | |
| MousePheno | fusion of atlas and odontoid process | 3.41e-05 | 10 | 94 | 3 | MP:0010701 | |
| MousePheno | abnormal testosterone level | 3.52e-05 | 92 | 94 | 6 | MP:0011385 | |
| MousePheno | abnormal reproductive system development | 5.33e-05 | 99 | 94 | 6 | MP:0003936 | |
| MousePheno | increased growth rate | 1.26e-04 | 15 | 94 | 3 | MP:0002865 | |
| MousePheno | abnormal prostate gland morphology | 1.29e-04 | 73 | 94 | 5 | MP:0001158 | |
| MousePheno | abnormal prostate gland anterior lobe morphology | 1.55e-04 | 16 | 94 | 3 | MP:0001163 | |
| Domain | Znf_hrmn_rcpt | 1.07e-05 | 46 | 119 | 5 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.07e-05 | 46 | 119 | 5 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.07e-05 | 46 | 119 | 5 | PS00031 | |
| Domain | ZnF_C4 | 1.07e-05 | 46 | 119 | 5 | SM00399 | |
| Domain | zf-C4 | 1.07e-05 | 46 | 119 | 5 | PF00105 | |
| Domain | - | 1.20e-05 | 47 | 119 | 5 | 1.10.565.10 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.33e-05 | 48 | 119 | 5 | IPR000536 | |
| Domain | HOLI | 1.33e-05 | 48 | 119 | 5 | SM00430 | |
| Domain | Hormone_recep | 1.33e-05 | 48 | 119 | 5 | PF00104 | |
| Domain | CUB | 2.17e-05 | 53 | 119 | 5 | PS01180 | |
| Domain | Homeobox_CS | 2.54e-05 | 186 | 119 | 8 | IPR017970 | |
| Domain | - | 3.10e-05 | 57 | 119 | 5 | 3.30.50.10 | |
| Domain | CUB_dom | 3.10e-05 | 57 | 119 | 5 | IPR000859 | |
| Domain | Znf_NHR/GATA | 3.38e-05 | 58 | 119 | 5 | IPR013088 | |
| Domain | LIM | 7.83e-05 | 69 | 119 | 5 | PF00412 | |
| Domain | - | 8.39e-05 | 70 | 119 | 5 | 2.10.110.10 | |
| Domain | LIM | 8.98e-05 | 71 | 119 | 5 | SM00132 | |
| Domain | Znf_LIM | 8.98e-05 | 71 | 119 | 5 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 8.98e-05 | 71 | 119 | 5 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 8.98e-05 | 71 | 119 | 5 | PS50023 | |
| Domain | DUF4074 | 1.20e-04 | 3 | 119 | 2 | IPR025281 | |
| Domain | DUF4074 | 1.20e-04 | 3 | 119 | 2 | PF13293 | |
| Domain | Requiem/DPF_N_dom | 1.20e-04 | 3 | 119 | 2 | IPR025750 | |
| Domain | Requiem_N | 1.20e-04 | 3 | 119 | 2 | PF14051 | |
| Domain | Homeobox | 1.28e-04 | 234 | 119 | 8 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.36e-04 | 236 | 119 | 8 | PS00027 | |
| Domain | HOX | 1.40e-04 | 237 | 119 | 8 | SM00389 | |
| Domain | HOMEOBOX_2 | 1.48e-04 | 239 | 119 | 8 | PS50071 | |
| Domain | Homeobox_dom | 1.48e-04 | 239 | 119 | 8 | IPR001356 | |
| Domain | CUB | 2.66e-04 | 49 | 119 | 4 | PF00431 | |
| Domain | Homeobox_metazoa | 2.75e-04 | 90 | 119 | 5 | IPR020479 | |
| Domain | Homeodomain-like | 2.77e-04 | 332 | 119 | 9 | IPR009057 | |
| Domain | CUB | 2.88e-04 | 50 | 119 | 4 | SM00042 | |
| Domain | - | 3.35e-04 | 52 | 119 | 4 | 2.60.120.290 | |
| Domain | HnRNP_R/Q_splicing_fac | 3.98e-04 | 5 | 119 | 2 | IPR006535 | |
| Domain | - | 4.62e-04 | 283 | 119 | 8 | 1.10.10.60 | |
| Domain | ANTENNAPEDIA | 4.63e-04 | 24 | 119 | 3 | PS00032 | |
| Domain | Sec23/24_helical_dom | 5.94e-04 | 6 | 119 | 2 | IPR006900 | |
| Domain | Sec23_24_beta_S | 5.94e-04 | 6 | 119 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 5.94e-04 | 6 | 119 | 2 | PF04810 | |
| Domain | Sec23_trunk | 5.94e-04 | 6 | 119 | 2 | PF04811 | |
| Domain | Sec23_helical | 5.94e-04 | 6 | 119 | 2 | PF04815 | |
| Domain | Sec23_BS | 5.94e-04 | 6 | 119 | 2 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 5.94e-04 | 6 | 119 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 5.94e-04 | 6 | 119 | 2 | IPR006895 | |
| Domain | Carn_acyl_trans | 8.28e-04 | 7 | 119 | 2 | IPR000542 | |
| Domain | Carn_acyltransf | 8.28e-04 | 7 | 119 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 8.28e-04 | 7 | 119 | 2 | PS00439 | |
| Domain | ACYLTRANSF_C_2 | 8.28e-04 | 7 | 119 | 2 | PS00440 | |
| Domain | MYTH4 | 1.41e-03 | 9 | 119 | 2 | PS51016 | |
| Domain | VHS | 1.41e-03 | 9 | 119 | 2 | PS50179 | |
| Domain | MyTH4 | 1.41e-03 | 9 | 119 | 2 | SM00139 | |
| Domain | VHS | 1.41e-03 | 9 | 119 | 2 | PF00790 | |
| Domain | MyTH4_dom | 1.41e-03 | 9 | 119 | 2 | IPR000857 | |
| Domain | MyTH4 | 1.41e-03 | 9 | 119 | 2 | PF00784 | |
| Domain | VHS | 1.41e-03 | 9 | 119 | 2 | SM00288 | |
| Domain | VHS_dom | 1.41e-03 | 9 | 119 | 2 | IPR002014 | |
| Domain | Nuclear_hrmn_rcpt | 3.14e-03 | 46 | 119 | 3 | IPR001723 | |
| Domain | Gelsolin | 3.48e-03 | 14 | 119 | 2 | PF00626 | |
| Domain | VitD_rcpt | 3.48e-03 | 14 | 119 | 2 | IPR000324 | |
| Domain | Gelsolin-like_dom | 3.48e-03 | 14 | 119 | 2 | IPR007123 | |
| Domain | Galectin_CRD | 4.00e-03 | 15 | 119 | 2 | IPR001079 | |
| Domain | Gal-bind_lectin | 4.00e-03 | 15 | 119 | 2 | PF00337 | |
| Domain | Gal-bind_lectin | 4.00e-03 | 15 | 119 | 2 | SM00908 | |
| Domain | GALECTIN | 4.00e-03 | 15 | 119 | 2 | PS51304 | |
| Domain | GLECT | 4.00e-03 | 15 | 119 | 2 | SM00276 | |
| Domain | Sushi_SCR_CCP_dom | 5.75e-03 | 57 | 119 | 3 | IPR000436 | |
| Domain | UIM | 5.76e-03 | 18 | 119 | 2 | PF02809 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 8.77e-07 | 28 | 91 | 5 | MM15042 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.26e-06 | 30 | 91 | 5 | M27323 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.49e-06 | 31 | 91 | 5 | M39522 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.38e-05 | 48 | 91 | 5 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.25e-05 | 53 | 91 | 5 | M8276 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.01e-04 | 38 | 91 | 4 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.01e-04 | 38 | 91 | 4 | MM15865 | |
| Pubmed | DPF1 ESR1 TBX21 SOX18 NR4A1 ARID1A NDRG2 CRIP3 CIC HOXA1 HOXA10 LHX2 LDB3 HOXD3 PIAS3 NFATC2 DPF3 GLI1 GLI2 ZFHX3 NR3C2 HOXB13 | 3.75e-15 | 709 | 119 | 22 | 22988430 | |
| Pubmed | ESR1 PER1 SOX18 NR4A1 CRIP3 CIC HOXA1 HOXA10 HOXB3 LDB3 ZFHX3 NR3C2 NR5A1 AJUBA HOXB13 | 2.08e-14 | 263 | 119 | 15 | 20932939 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | CEBPE ESR1 TBX21 SOX18 NR4A1 MIDEAS AR CIC HOXA1 THAP4 LHX2 HOXB3 HOXC12 HOXD3 NFATC2 EGR1 GLI1 GLI2 BHLHE22 ZFHX3 NR3C2 NR5A1 HOXB13 | 5.96e-14 | 908 | 119 | 23 | 19274049 |
| Pubmed | ESR1 NR4A1 AR HOXA1 HOXA10 HOXB3 HOXC12 HOXD3 NR3C2 NR5A1 HOXB13 | 3.30e-13 | 118 | 119 | 11 | 16971476 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | CEBPE ESR1 TBX21 PER1 DAZAP2 SSBP2 AR CIC HOXA1 HOXA10 LHX2 HOXC12 HOXD3 PIAS3 EGR1 GLI1 CTBP1 NR5A1 HOXB13 RBFOX2 RAI1 | 2.43e-12 | 877 | 119 | 21 | 20211142 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | DPF1 CEBPE ESR1 TBX21 SOX18 NR4A1 HOXA1 HOXA10 HOXC12 HOXD3 NFATC2 EGR1 GLI2 BHLHE22 NR3C2 NR5A1 HOXB13 | 5.87e-12 | 544 | 119 | 17 | 28473536 |
| Pubmed | DPF1 ZNF703 UBAP2 ESR1 PPP1R13B SSBP2 ARID1A FIGN MIDEAS CIC HOXA10 LHX2 FAM120A ZNF608 PRCC DPF3 GLI2 HGS CTBP1 ZFHX3 FKBP4 SYNCRIP HNRNPR | 5.42e-10 | 1429 | 119 | 23 | 35140242 | |
| Pubmed | 3.57e-09 | 38 | 119 | 6 | 11857506 | ||
| Pubmed | Quantification of Hox and surfactant protein-B transcription during murine lung development. | 4.93e-09 | 40 | 119 | 6 | 19204410 | |
| Pubmed | 5.76e-09 | 41 | 119 | 6 | 32479258 | ||
| Pubmed | 7.77e-09 | 43 | 119 | 6 | 22701719 | ||
| Pubmed | New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice. | 1.99e-08 | 50 | 119 | 6 | 28188179 | |
| Pubmed | VPS37C ZNF703 ANXA7 BAG4 STAM LGALS3 PEF1 SEC24C HGS SYNCRIP | 2.48e-08 | 261 | 119 | 10 | 33277362 | |
| Pubmed | Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. | 2.69e-08 | 10 | 119 | 4 | 16466956 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBKBP1 HEBP2 ANXA7 INSR MAGI3 SRCIN1 ARID1A AR THAP4 NLGN3 FAM120A ZNF608 GLI2 LPP CTBP1 ZFHX3 LTBR CSMD1 RBFOX2 RAI1 MOCOS | 3.33e-08 | 1489 | 119 | 21 | 28611215 |
| Pubmed | Interaction network of human early embryonic transcription factors. | DPF1 ZNF703 TBKBP1 SSBP2 ARID1A MIDEAS ZNF608 DPF3 CTBP1 ZFHX3 RAI1 | 3.78e-08 | 351 | 119 | 11 | 38297188 |
| Pubmed | SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines. | 3.91e-08 | 3 | 119 | 3 | 26588701 | |
| Pubmed | Gli activity is critical at multiple stages of embryonic mammary and nipple development. | 1.27e-07 | 14 | 119 | 4 | 24260306 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 27760825 | ||
| Pubmed | A distinct Hox code for the branchial region of the vertebrate head. | 1.73e-07 | 15 | 119 | 4 | 1682814 | |
| Pubmed | 1.98e-07 | 38 | 119 | 5 | 15042701 | ||
| Pubmed | 2.26e-07 | 39 | 119 | 5 | 33257809 | ||
| Pubmed | 3.33e-07 | 191 | 119 | 8 | 24146773 | ||
| Pubmed | Clathrin anchors deubiquitinating enzymes, AMSH and AMSH-like protein, on early endosomes. | 3.89e-07 | 5 | 119 | 3 | 16716190 | |
| Pubmed | 4.21e-07 | 44 | 119 | 5 | 1973146 | ||
| Pubmed | Secretory protein trafficking and organelle dynamics in living cells. | 4.96e-07 | 85 | 119 | 6 | 11031247 | |
| Pubmed | 5.89e-07 | 47 | 119 | 5 | 1358459 | ||
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 8.07e-07 | 50 | 119 | 5 | 27716508 | |
| Pubmed | Nuclear receptors in Leydig cell gene expression and function. | 9.09e-07 | 22 | 119 | 4 | 20375256 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 9.69e-07 | 220 | 119 | 8 | 35785414 | |
| Pubmed | 1.10e-06 | 23 | 119 | 4 | 25505333 | ||
| Pubmed | 1.31e-06 | 24 | 119 | 4 | 32497091 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 11117529 | ||
| Pubmed | 2.90e-06 | 29 | 119 | 4 | 2574852 | ||
| Pubmed | 3.23e-06 | 9 | 119 | 3 | 33530552 | ||
| Pubmed | 3.33e-06 | 30 | 119 | 4 | 24073291 | ||
| Pubmed | 4.20e-06 | 268 | 119 | 8 | 33640491 | ||
| Pubmed | Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors. | 4.61e-06 | 10 | 119 | 3 | 36109631 | |
| Pubmed | 4.61e-06 | 10 | 119 | 3 | 19842175 | ||
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 29604273 | ||
| Pubmed | 6.99e-06 | 77 | 119 | 5 | 21525287 | ||
| Pubmed | 7.45e-06 | 78 | 119 | 5 | 28611094 | ||
| Pubmed | 8.40e-06 | 12 | 119 | 3 | 36459481 | ||
| Pubmed | 8.79e-06 | 38 | 119 | 4 | 1683707 | ||
| Pubmed | 1.09e-05 | 13 | 119 | 3 | 9115274 | ||
| Pubmed | Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. | 1.09e-05 | 13 | 119 | 3 | 9636069 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33125874 | ||
| Pubmed | Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling. | 1.16e-05 | 2 | 119 | 2 | 27893742 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18559568 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 34953044 | ||
| Pubmed | Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors. | 1.16e-05 | 2 | 119 | 2 | 25132524 | |
| Pubmed | Direct androgen receptor control of sexually dimorphic gene expression in the mammalian kidney. | 1.16e-05 | 2 | 119 | 2 | 37673062 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32392092 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17187234 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28974548 | ||
| Pubmed | Rhythmic interaction between Period1 mRNA and hnRNP Q leads to circadian time-dependent translation. | 1.16e-05 | 2 | 119 | 2 | 22124155 | |
| Pubmed | Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes. | 1.16e-05 | 2 | 119 | 2 | 30695055 | |
| Pubmed | The Role of the Androgen Receptor Signaling in Breast Malignancies. | 1.16e-05 | 2 | 119 | 2 | 29187427 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9162064 | ||
| Pubmed | Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. | 1.16e-05 | 2 | 119 | 2 | 12165851 | |
| Pubmed | Androgen signaling negatively controls group 2 innate lymphoid cells. | 1.16e-05 | 2 | 119 | 2 | 28484078 | |
| Pubmed | GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression. | 1.16e-05 | 2 | 119 | 2 | 32766732 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15175043 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33323970 | ||
| Pubmed | Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. | 1.16e-05 | 2 | 119 | 2 | 22508765 | |
| Pubmed | Sex hormones regulate metainflammation in diet-induced obesity in mice. | 1.16e-05 | 2 | 119 | 2 | 34599964 | |
| Pubmed | T-bet expression is regulated by EGR1-mediated signaling in activated T cells. | 1.16e-05 | 2 | 119 | 2 | 19307156 | |
| Pubmed | Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. | 1.16e-05 | 2 | 119 | 2 | 22986745 | |
| Pubmed | Expression of sexual hormones receptors in oral squamous cell carcinoma. | 1.16e-05 | 2 | 119 | 2 | 21781458 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25076121 | ||
| Pubmed | The roles of galectin-3 and galectin-4 in the idiopatic Parkinson disease and its progression. | 1.16e-05 | 2 | 119 | 2 | 31147178 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27402268 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25296754 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24373698 | ||
| Pubmed | Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes. | 1.16e-05 | 2 | 119 | 2 | 26173257 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19191023 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9407053 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17638386 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19137262 | ||
| Pubmed | The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. | 1.16e-05 | 2 | 119 | 2 | 9647203 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23117840 | ||
| Pubmed | Induction of mPer1 expression by GnRH in pituitary gonadotrope cells involves EGR-1. | 1.16e-05 | 2 | 119 | 2 | 19616057 | |
| Pubmed | Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies. | 1.16e-05 | 2 | 119 | 2 | 30445651 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35640239 | ||
| Pubmed | Brain-specific angiogenesis inhibitor 2 (BAI2) may be activated by proteolytic processing. | 1.16e-05 | 2 | 119 | 2 | 20367554 | |
| Pubmed | The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men. | 1.16e-05 | 2 | 119 | 2 | 11564035 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25599767 | ||
| Pubmed | Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. | 1.16e-05 | 2 | 119 | 2 | 16434164 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 37315534 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9466414 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20353269 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23996526 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 14960012 | ||
| Pubmed | AR collaborates with ERα in aromatase inhibitor-resistant breast cancer. | 1.16e-05 | 2 | 119 | 2 | 25178514 | |
| Pubmed | Clathrin Heavy Chain Interacts With Estrogen Receptor α and Modulates 17β-Estradiol Signaling. | 1.16e-05 | 2 | 119 | 2 | 25860340 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11532964 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32109207 | ||
| Pubmed | The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. | 1.16e-05 | 2 | 119 | 2 | 33462444 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11994298 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28188754 | ||
| Interaction | PAX9 interactions | VPS37C ZNF703 TBX21 ARID1A FIGN MIDEAS CIC HOXA1 ZNF608 ZFHX3 | 4.75e-09 | 130 | 118 | 10 | int:PAX9 |
| Interaction | RUNX1 interactions | PLEKHB2 VPS37C BAG4 DAZAP2 MAGI3 ARID1A AR CIC NFATC2 HGS CLTC CTBP1 SYNCRIP HNRNPR | 6.76e-09 | 324 | 118 | 14 | int:RUNX1 |
| Interaction | TBX2 interactions | 1.16e-07 | 40 | 118 | 6 | int:TBX2 | |
| Interaction | CRX interactions | DPF1 VPS37C TNS2 ARID1A MIDEAS LGALS3 ZNF608 DPF3 HGS ZFHX3 RAI1 | 2.99e-07 | 254 | 118 | 11 | int:CRX |
| Interaction | TLE3 interactions | ZNF703 ESR1 STAM ARID1A FIGN MIDEAS AR CIC ZNF608 EGR1 GLI2 ZFHX3 CRTC2 | 3.21e-07 | 376 | 118 | 13 | int:TLE3 |
| Interaction | TBR1 interactions | 3.33e-07 | 113 | 118 | 8 | int:TBR1 | |
| Interaction | IRF4 interactions | 6.67e-07 | 85 | 118 | 7 | int:IRF4 | |
| Interaction | ERG interactions | 7.73e-07 | 223 | 118 | 10 | int:ERG | |
| Interaction | TEAD1 interactions | 9.52e-07 | 176 | 118 | 9 | int:TEAD1 | |
| Interaction | TLX3 interactions | DPF1 ZNF703 FNTB TBX21 PER1 ARID1A MIDEAS AR CIC ZNF608 ZFHX3 | 1.15e-06 | 291 | 118 | 11 | int:TLX3 |
| Interaction | ALG13 interactions | ZNF703 BAG4 ARID1A HOXA1 FAM120A ZNF608 RBFOX2 SYNCRIP HNRNPR | 1.32e-06 | 183 | 118 | 9 | int:ALG13 |
| Interaction | PIAS3 interactions | 1.42e-06 | 95 | 118 | 7 | int:PIAS3 | |
| Interaction | NFIB interactions | 1.90e-06 | 142 | 118 | 8 | int:NFIB | |
| Interaction | TOM1 interactions | 2.62e-06 | 104 | 118 | 7 | int:TOM1 | |
| Interaction | ARID2 interactions | 3.32e-06 | 153 | 118 | 8 | int:ARID2 | |
| Interaction | PAX8 interactions | 4.05e-06 | 111 | 118 | 7 | int:PAX8 | |
| Interaction | AR interactions | DPF1 ESR1 SSBP2 ARID1A MIDEAS AR CIC PIAS3 ZNF608 GLI2 CLTC CTBP1 ZFHX3 NR3C2 NR5A1 FKBP4 HOXB13 RAI1 HNRNPR | 4.83e-06 | 992 | 118 | 19 | int:AR |
| Interaction | TBXT interactions | 5.43e-06 | 116 | 118 | 7 | int:TBXT | |
| Interaction | PAX7 interactions | 8.44e-06 | 124 | 118 | 7 | int:PAX7 | |
| Interaction | ALX4 interactions | 8.85e-06 | 48 | 118 | 5 | int:ALX4 | |
| Interaction | TLX1 interactions | 8.95e-06 | 175 | 118 | 8 | int:TLX1 | |
| Interaction | SRA1 interactions | 9.27e-06 | 83 | 118 | 6 | int:SRA1 | |
| Interaction | PAX6 interactions | DPF1 ARID1A MIDEAS AR CIC HOXA1 LHX2 HOXC12 ZNF608 HGS ZFHX3 | 1.03e-05 | 366 | 118 | 11 | int:PAX6 |
| Interaction | TLE5 interactions | VPS37C UBAP2 BAG4 DAZAP2 TNS2 AR HOXA1 LHX2 NLGN3 TRMT2A HGS ZFHX3 | 1.14e-05 | 443 | 118 | 12 | int:TLE5 |
| Interaction | TEKT5 interactions | 1.20e-05 | 51 | 118 | 5 | int:TEKT5 | |
| Interaction | SMARCD2 interactions | 1.24e-05 | 183 | 118 | 8 | int:SMARCD2 | |
| Interaction | PIN1 interactions | TNS2 SSBP2 AR HOXA1 TRMT2A NFATC2 EGR1 GLI1 NR5A1 AJUBA RAI1 | 1.57e-05 | 383 | 118 | 11 | int:PIN1 |
| Interaction | UBQLN2 interactions | PLEKHB2 VPS37C ZNF703 ANXA7 BAG4 INSR DAZAP2 STAM LGALS3 FZD7 PEF1 FAM120A SEC24C HGS RBFOX2 HNRNPR | 1.66e-05 | 797 | 118 | 16 | int:UBQLN2 |
| Interaction | FOXI1 interactions | 1.68e-05 | 92 | 118 | 6 | int:FOXI1 | |
| Interaction | SMARCA4 interactions | DPF1 ESR1 TBX21 NR4A1 ARID1A AR CIC LHX2 NFATC2 EGR1 DPF3 GLI1 | 1.73e-05 | 462 | 118 | 12 | int:SMARCA4 |
| Interaction | EP300 interactions | ESR1 TBX21 PPP1R13B SSBP2 NR4A1 ARID1A AR HOXA10 HOXB3 SEC24C PIAS3 NFATC2 EGR1 PRCC DPF3 CLTC CTBP1 NR3C2 TMC5 AJUBA CRTC2 HNRNPR | 1.88e-05 | 1401 | 118 | 22 | int:EP300 |
| Interaction | GATA2 interactions | 2.27e-05 | 199 | 118 | 8 | int:GATA2 | |
| Interaction | SS18L1 interactions | 2.41e-05 | 98 | 118 | 6 | int:SS18L1 | |
| Interaction | ARID5A interactions | 2.55e-05 | 147 | 118 | 7 | int:ARID5A | |
| Interaction | C1orf94 interactions | 3.19e-05 | 103 | 118 | 6 | int:C1orf94 | |
| Interaction | SMARCD3 interactions | 3.96e-05 | 107 | 118 | 6 | int:SMARCD3 | |
| Interaction | DPF2 interactions | 3.97e-05 | 349 | 118 | 10 | int:DPF2 | |
| Interaction | SMARCD1 interactions | 3.97e-05 | 349 | 118 | 10 | int:SMARCD1 | |
| Interaction | SPATA12 interactions | 4.14e-05 | 12 | 118 | 3 | int:SPATA12 | |
| Interaction | ZFHX3 interactions | 4.39e-05 | 109 | 118 | 6 | int:ZFHX3 | |
| Interaction | SMARCE1 interactions | 4.90e-05 | 287 | 118 | 9 | int:SMARCE1 | |
| Interaction | CREBBP interactions | ESR1 ANXA7 TBX21 ARID1A AR HOXA10 HOXB3 PIAS3 NFATC2 EGR1 CTBP1 NR3C2 NR5A1 | 4.96e-05 | 599 | 118 | 13 | int:CREBBP |
| Interaction | HGS interactions | PLEKHB2 VPS37C UBAP2 INSR DAZAP2 STAM FIGN CIC PEF1 HGS CLTC LTBR | 5.79e-05 | 523 | 118 | 12 | int:HGS |
| Interaction | LDB1 interactions | 5.93e-05 | 115 | 118 | 6 | int:LDB1 | |
| Interaction | TSG101 interactions | 7.44e-05 | 303 | 118 | 9 | int:TSG101 | |
| Interaction | SP7 interactions | 7.63e-05 | 304 | 118 | 9 | int:SP7 | |
| Interaction | BCL7A interactions | 8.63e-05 | 123 | 118 | 6 | int:BCL7A | |
| Interaction | NR0B1 interactions | 8.67e-05 | 40 | 118 | 4 | int:NR0B1 | |
| Interaction | PITX1 interactions | 1.03e-04 | 127 | 118 | 6 | int:PITX1 | |
| Interaction | LASP1 interactions | 1.04e-04 | 247 | 118 | 8 | int:LASP1 | |
| Interaction | DAZAP2 interactions | 1.13e-04 | 186 | 118 | 7 | int:DAZAP2 | |
| Interaction | WWP2 interactions | VPS37C UBAP2 BAG4 PPP1R13B STAM ARID1A MIDEAS SEC24D PEF1 FAM120A SEC24C HGS CLTC SYNCRIP HNRNPR | 1.16e-04 | 840 | 118 | 15 | int:WWP2 |
| Interaction | GATA3 interactions | 1.17e-04 | 187 | 118 | 7 | int:GATA3 | |
| Interaction | NFIA interactions | 1.21e-04 | 188 | 118 | 7 | int:NFIA | |
| Interaction | MAPK1IP1L interactions | 1.38e-04 | 45 | 118 | 4 | int:MAPK1IP1L | |
| Interaction | CLNS1A interactions | 1.43e-04 | 193 | 118 | 7 | int:CLNS1A | |
| Interaction | PBX1 interactions | 1.43e-04 | 85 | 118 | 5 | int:PBX1 | |
| Interaction | PAX2 interactions | 1.43e-04 | 85 | 118 | 5 | int:PAX2 | |
| Interaction | NR3C2 interactions | 1.51e-04 | 46 | 118 | 4 | int:NR3C2 | |
| Interaction | GSC interactions | 1.59e-04 | 87 | 118 | 5 | int:GSC | |
| Interaction | CIC interactions | ESR1 AR CIC HOXA10 LHX2 TRMT2A SEC24C NFATC2 HGS CLTC CTBP1 ZFHX3 SYNCRIP | 1.59e-04 | 673 | 118 | 13 | int:CIC |
| Interaction | IGFN1 interactions | 1.64e-04 | 47 | 118 | 4 | int:IGFN1 | |
| Interaction | SS18 interactions | 1.68e-04 | 88 | 118 | 5 | int:SS18 | |
| Interaction | TFAP2D interactions | 1.77e-04 | 89 | 118 | 5 | int:TFAP2D | |
| Interaction | RBPMS interactions | 1.78e-04 | 340 | 118 | 9 | int:RBPMS | |
| Interaction | NFATC2 interactions | 1.78e-04 | 200 | 118 | 7 | int:NFATC2 | |
| Interaction | BCL9L interactions | 1.78e-04 | 48 | 118 | 4 | int:BCL9L | |
| Interaction | VPS37C interactions | 1.83e-04 | 141 | 118 | 6 | int:VPS37C | |
| Interaction | ZNF34 interactions | 1.93e-04 | 49 | 118 | 4 | int:ZNF34 | |
| Interaction | FEV interactions | 1.95e-04 | 203 | 118 | 7 | int:FEV | |
| Interaction | TRPS1 interactions | 1.97e-04 | 143 | 118 | 6 | int:TRPS1 | |
| Interaction | PDCD6 interactions | 2.01e-04 | 204 | 118 | 7 | int:PDCD6 | |
| Interaction | SOX10 interactions | 2.07e-04 | 92 | 118 | 5 | int:SOX10 | |
| Interaction | TEX13B interactions | 2.07e-04 | 20 | 118 | 3 | int:TEX13B | |
| Interaction | NCOA1 interactions | 2.21e-04 | 146 | 118 | 6 | int:NCOA1 | |
| Interaction | CPEB1 interactions | 2.21e-04 | 146 | 118 | 6 | int:CPEB1 | |
| Interaction | IST1 interactions | 2.29e-04 | 94 | 118 | 5 | int:IST1 | |
| Interaction | STAM2 interactions | 2.29e-04 | 147 | 118 | 6 | int:STAM2 | |
| Interaction | PIAS1 interactions | 2.35e-04 | 353 | 118 | 9 | int:PIAS1 | |
| Interaction | DPF1 interactions | 2.41e-04 | 95 | 118 | 5 | int:DPF1 | |
| Interaction | BCL7B interactions | 2.41e-04 | 95 | 118 | 5 | int:BCL7B | |
| Interaction | OTUB2 interactions | 2.53e-04 | 96 | 118 | 5 | int:OTUB2 | |
| Interaction | ATXN1L interactions | 2.55e-04 | 150 | 118 | 6 | int:ATXN1L | |
| Interaction | CTNNB1 interactions | ABCA4 ESR1 PPP1R13B DAZAP2 MAGI3 SRCIN1 NR4A1 NDRG2 AR LGALS3 SEC24C EGR1 CTBP1 NR5A1 FKBP4 SYNCRIP | 2.64e-04 | 1009 | 118 | 16 | int:CTNNB1 |
| Interaction | SOX9 interactions | 2.65e-04 | 97 | 118 | 5 | int:SOX9 | |
| Interaction | HSPA2 interactions | 2.65e-04 | 440 | 118 | 10 | int:HSPA2 | |
| Interaction | TFAP4 interactions | 2.84e-04 | 153 | 118 | 6 | int:TFAP4 | |
| Interaction | SEC13 interactions | 2.84e-04 | 216 | 118 | 7 | int:SEC13 | |
| Interaction | ZNRD2 interactions | 2.97e-04 | 288 | 118 | 8 | int:ZNRD2 | |
| Interaction | TP53BP1 interactions | UBAP2 ESR1 ANXA7 ARID1A CIC TRMT2A PIAS3 NFATC2 EGR1 PRCC HGS | 2.98e-04 | 533 | 118 | 11 | int:TP53BP1 |
| Interaction | MYPOP interactions | 3.02e-04 | 55 | 118 | 4 | int:MYPOP | |
| Interaction | VAV3 interactions | 3.02e-04 | 55 | 118 | 4 | int:VAV3 | |
| Interaction | DCAF7 interactions | 3.19e-04 | 368 | 118 | 9 | int:DCAF7 | |
| Interaction | BAG4 interactions | 3.54e-04 | 224 | 118 | 7 | int:BAG4 | |
| Interaction | KLF4 interactions | 3.61e-04 | 160 | 118 | 6 | int:KLF4 | |
| Interaction | KDM2B interactions | 3.73e-04 | 161 | 118 | 6 | int:KDM2B | |
| Interaction | NFIX interactions | 3.84e-04 | 227 | 118 | 7 | int:NFIX | |
| Interaction | PEF1 interactions | 4.36e-04 | 108 | 118 | 5 | int:PEF1 | |
| Interaction | NFATC1 interactions | 4.68e-04 | 168 | 118 | 6 | int:NFATC1 | |
| Interaction | UBAP2 interactions | 4.98e-04 | 170 | 118 | 6 | int:UBAP2 | |
| Cytoband | 8p11.23 | 4.32e-04 | 12 | 119 | 2 | 8p11.23 | |
| Cytoband | 12q13.13 | 7.21e-04 | 67 | 119 | 3 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 8.54e-04 | 423 | 119 | 6 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.11e-03 | 298 | 119 | 5 | chr5q31 | |
| GeneFamily | HOXL subclass homeoboxes | 1.34e-07 | 52 | 83 | 6 | 518 | |
| GeneFamily | Nuclear hormone receptors | 2.94e-06 | 49 | 83 | 5 | 71 | |
| GeneFamily | ESCRT-0 | 6.23e-05 | 3 | 83 | 2 | 1115 | |
| GeneFamily | LIM domain containing | 1.55e-04 | 59 | 83 | 4 | 1218 | |
| GeneFamily | Galectins | 2.10e-03 | 15 | 83 | 2 | 629 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.28e-03 | 57 | 83 | 3 | 1179 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | ESR1 TBX21 ADGRB2 PPP1R13B CSMD3 LGALS3 HOXA1 HOXA10 LHX2 HOXB3 DUOX1 HOXC12 HOXD3 DPF3 BHLHE22 ZFHX3 CSMD1 PRRT1 HOXB13 | 6.60e-07 | 1115 | 119 | 19 | M10371 |
| Coexpression | BENPORATH_SUZ12_TARGETS | ZNF703 TBX21 ADGRB2 PPP1R13B CSMD3 LGALS3 LHX2 HOXB3 DUOX1 HOXC12 HOXD3 DPF3 BHLHE22 ZFHX3 CSMD1 AJUBA HOXB13 | 4.45e-06 | 1035 | 119 | 17 | M9898 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ADGRB2 SOX18 FIGN NDRG2 LGALS3 FZD7 LHX2 NFATC2 GLI2 BHLHE22 LHFPL2 KCNK6 LTBR AJUBA FOXD1 MOCOS DNAH11 | 7.25e-06 | 1074 | 119 | 17 | M1941 |
| Coexpression | BENPORATH_PRC2_TARGETS | TBX21 CSMD3 LGALS3 LHX2 HOXB3 DUOX1 HOXC12 HOXD3 DPF3 BHLHE22 ZFHX3 CSMD1 HOXB13 | 8.38e-06 | 650 | 119 | 13 | M8448 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | CEACAM5 ESR1 FIGN AR HOXA10 HOXB3 SEC24D LDB3 PIAS3 DPF3 KCNK6 AJUBA RBFOX2 RAI1 | 1.37e-05 | 786 | 119 | 14 | M10961 |
| Coexpression | BENPORATH_EED_TARGETS | TBX21 ARID1A CSMD3 LGALS3 HOXA1 HOXA10 LHX2 HOXB3 DUOX1 HOXC12 HOXD3 DPF3 BHLHE22 ZFHX3 CSMD1 HOXB13 | 2.44e-05 | 1059 | 119 | 16 | M7617 |
| Coexpression | CYCLIN_D1_KE_.V1_UP | 2.49e-05 | 188 | 119 | 7 | M2648 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 3.35e-05 | 197 | 119 | 7 | M12824 | |
| Coexpression | GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP | 3.58e-05 | 199 | 119 | 7 | M8435 | |
| Coexpression | GSE17721_0.5H_VS_8H_CPG_BMDC_UP | 3.69e-05 | 200 | 119 | 7 | M4126 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS | 1.04e-04 | 102 | 119 | 5 | M43620 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.07e-04 | 54 | 119 | 4 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.07e-04 | 54 | 119 | 4 | M2372 | |
| Coexpression | LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B | 1.09e-04 | 103 | 119 | 5 | M39240 | |
| Coexpression | IBRAHIM_NRF1_DOWN | 1.17e-04 | 167 | 119 | 6 | M42512 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 3.90e-06 | 166 | 117 | 8 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 4.08e-06 | 167 | 117 | 8 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_200 | 3.57e-05 | 34 | 117 | 4 | gudmap_developingGonad_e16.5_epididymis_200_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_100 | 9.61e-05 | 83 | 117 | 5 | gudmap_developingGonad_e18.5_epididymis_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.61e-05 | 83 | 117 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_1000 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-07 | 184 | 119 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-07 | 184 | 119 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-07 | 184 | 119 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-07 | 185 | 119 | 7 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-07 | 185 | 119 | 7 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | P28-Mesenchymal-myocytic_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.27e-07 | 194 | 119 | 7 | 83e45441c74b7f50b6725876b583229280179dc2 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 9.59e-07 | 195 | 119 | 7 | e8ab3122f81cb22920becd6611cbd9f00db19d50 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-07 | 195 | 119 | 7 | 66caa5c063184e7d3d653c8f6c289555cb36fa82 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-07 | 195 | 119 | 7 | ed74c113074fb5d3c42f2330b0e6042d32c3611a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-07 | 195 | 119 | 7 | 17c4d3b59cd0d79ce9ae5dde95586f3e923db16f | |
| ToppCell | severe-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.14e-06 | 200 | 119 | 7 | 26e04ea276dbca5cde48335c401269c7123b54d2 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-06 | 86 | 119 | 5 | d20ec61a572b11641647358a546334b217c694f3 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 4.75e-06 | 161 | 119 | 6 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 167 | 119 | 6 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 167 | 119 | 6 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 167 | 119 | 6 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-06 | 168 | 119 | 6 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 170 | 119 | 6 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-06 | 172 | 119 | 6 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.42e-06 | 174 | 119 | 6 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-06 | 178 | 119 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-06 | 180 | 119 | 6 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-06 | 180 | 119 | 6 | e5c50d85e8df4e15f3e58f1f1d5aa25a375735de | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-06 | 180 | 119 | 6 | f5d757786a3be20756ad8b30edd53ff80b824974 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 107 | 119 | 5 | 0b45241cc52d10225966b49941efb66997184158 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 107 | 119 | 5 | 2f84089acc794b43ee59452dc8f90ca7261ebd41 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 185 | 119 | 6 | 512a195ebbae445afe3722a3943020080daf2f3c | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.05e-05 | 185 | 119 | 6 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-05 | 186 | 119 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 186 | 119 | 6 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 187 | 119 | 6 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 187 | 119 | 6 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 187 | 119 | 6 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.19e-05 | 189 | 119 | 6 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-05 | 190 | 119 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 191 | 119 | 6 | 9d3fa8d8138700640cc7927521c7635299df697d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-05 | 191 | 119 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.26e-05 | 191 | 119 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 191 | 119 | 6 | cb75e6c36dbe2e091e407d691c063ec7c4fd5f90 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 191 | 119 | 6 | d04ed1e04b8cb904237d8e8388fe7740c724237b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 191 | 119 | 6 | b2cffea7860dd590b505ee0ebd51aa1978cb5e64 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.27e-05 | 112 | 119 | 5 | 88fcd0dc12b5c00804381fb7dd59a6a2a9f37419 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.27e-05 | 112 | 119 | 5 | fd4cc5190626cb262aae0a7f04559b0e9757270e | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.27e-05 | 112 | 119 | 5 | d652e6fae433a6b56bf2a448fba2cf6c5e558905 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-05 | 192 | 119 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.30e-05 | 192 | 119 | 6 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 1.30e-05 | 192 | 119 | 6 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 192 | 119 | 6 | e5117cdb8af220f60bd1410262078c0306667b4a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.38e-05 | 194 | 119 | 6 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 194 | 119 | 6 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 194 | 119 | 6 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.38e-05 | 194 | 119 | 6 | 08fad7591c20568de797cf8e206de2d0b1d78aab | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 1.42e-05 | 195 | 119 | 6 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-05 | 198 | 119 | 6 | e1a0c809302a3b304775bd708201ad412a98d711 | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.55e-05 | 198 | 119 | 6 | 09009cc966bf1503c3b15dfa079a6c5f6ad1f507 | |
| ToppCell | 15-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.59e-05 | 199 | 119 | 6 | e0099aa95cf3ec08d7688cc97f4b917fce65a7a3 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(51)_cDC1|Sigmoid / shred on region, Cell_type, and subtype | 1.64e-05 | 200 | 119 | 6 | 4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Sigmoid / Region, Cell class and subclass | 1.64e-05 | 200 | 119 | 6 | 3523ec986e8c9e176e08836c974b1de8b56d8b16 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 200 | 119 | 6 | 69295705fc614c2687f2b6c8e6aa0c6717841008 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.78e-05 | 120 | 119 | 5 | a6d0406a174d46ce06b41280292931954af88a59 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 129 | 119 | 5 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.92e-05 | 133 | 119 | 5 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.27e-05 | 144 | 119 | 5 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.02e-05 | 149 | 119 | 5 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.06e-05 | 155 | 119 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 156 | 119 | 5 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 156 | 119 | 5 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 156 | 119 | 5 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 156 | 119 | 5 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 156 | 119 | 5 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 156 | 119 | 5 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.83e-05 | 159 | 119 | 5 | 7a5c94c87b73f928d4daee507f32cbe7d90e4478 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.25e-05 | 161 | 119 | 5 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.68e-05 | 163 | 119 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.68e-05 | 163 | 119 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.91e-05 | 164 | 119 | 5 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 166 | 119 | 5 | e841e62cb20235d6233f78f4155fb8c0ffb1ef1b | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 166 | 119 | 5 | 3ca3ddb663644f0e7f70f9b75833bb54cd9191d3 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 166 | 119 | 5 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.61e-05 | 167 | 119 | 5 | 7cb5b52aaa5b595fe2e97d9e175294ea8d63b165 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-05 | 167 | 119 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | severe-Myeloid-mDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.61e-05 | 167 | 119 | 5 | 50b1cea9048bd8df9aff3fb9a548443f950d1090 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.86e-05 | 168 | 119 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 8.86e-05 | 168 | 119 | 5 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 168 | 119 | 5 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.11e-05 | 169 | 119 | 5 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 169 | 119 | 5 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.37e-05 | 170 | 119 | 5 | 7bba77ae34a0259fad6ee98cf665ff50f77a1328 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.37e-05 | 170 | 119 | 5 | a43b977a7fe745536cf96b7c080397d9fa73086b | |
| ToppCell | CD8+_Memory_T_cell-FLU-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.90e-05 | 172 | 119 | 5 | 45ac433dbb3796f69e886c04457b2971403050ee | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.97e-05 | 90 | 119 | 4 | 3817a5b0235e632d976ea565175bdbebbd959bf0 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.97e-05 | 90 | 119 | 4 | a528f5dcee1a356dea89ff2588d2e0f276f2d5fc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 173 | 119 | 5 | b75353fcbc9f8cdb21d4f10ddbc93a83fd797a3c | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-04 | 173 | 119 | 5 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | CV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 1.04e-04 | 174 | 119 | 5 | 26544cc5f51cb4dc1251e62d9f80b6c956194d38 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 175 | 119 | 5 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 175 | 119 | 5 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 175 | 119 | 5 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 176 | 119 | 5 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| Computational | Genes in the cancer module 123. | 8.64e-05 | 247 | 80 | 9 | MODULE_123 | |
| Drug | testosterone decanoate | 5.41e-07 | 4 | 118 | 3 | CID000155143 | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 8.98e-07 | 197 | 118 | 9 | 3361_UP | |
| Drug | 3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide | 1.35e-06 | 5 | 118 | 3 | CID000115209 | |
| Drug | 3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide | 2.68e-06 | 6 | 118 | 3 | ctd:C101850 | |
| Drug | 2,6-dihydroxybenzoic acid | 3.70e-06 | 175 | 118 | 8 | CID000009338 | |
| Drug | 2,4,6-trichlorophenyl 4-nitrophenyl ether | 4.68e-06 | 7 | 118 | 3 | ctd:C010422 | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 5.36e-06 | 184 | 118 | 8 | 4369_UP | |
| Drug | aldosterone | ESR1 INSR PER1 NR4A1 NDRG2 HGS NR3C2 NR5A1 MMP15 RBFOX2 PCOLCE | 7.12e-06 | 397 | 118 | 11 | CID000005839 |
| Drug | mespirenone | 7.46e-06 | 8 | 118 | 3 | CID000065660 | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.18e-06 | 198 | 118 | 8 | 6976_UP | |
| Drug | Methamphetamine | B3GALT4 TIMM17B ESR1 INSR PER1 SOX18 TNS2 CHAT NR4A1 ARID1A AR REXO1 CIC ARAP3 STPG1 EGR1 GLI1 CSMD1 FKBP4 CHAC1 CRTC2 | 9.77e-06 | 1401 | 118 | 21 | ctd:D008694 |
| Drug | chlornitrofen | 1.59e-05 | 10 | 118 | 3 | CID000015788 | |
| Drug | 3,4,3',4'-tetrachloroazobenzene | 2.17e-05 | 11 | 118 | 3 | ctd:C013279 | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.21e-05 | 162 | 118 | 7 | 1486_UP | |
| Drug | Spironolactone | 2.66e-05 | 2 | 118 | 2 | DB00421 | |
| Drug | Pcb-155 | 2.66e-05 | 2 | 118 | 2 | CID003080840 | |
| Drug | ryodipine | 2.66e-05 | 2 | 118 | 2 | ctd:C045912 | |
| Drug | Chlorobenzenes | 2.66e-05 | 2 | 118 | 2 | ctd:D002722 | |
| Drug | spirorenone | 2.66e-05 | 2 | 118 | 2 | CID000068923 | |
| Drug | butyl-methoxydibenzoylmethane | 2.66e-05 | 2 | 118 | 2 | ctd:C474135 | |
| Drug | cyoctol | 2.66e-05 | 2 | 118 | 2 | CID000055994 | |
| Drug | prorenoate | 2.66e-05 | 2 | 118 | 2 | CID000162581 | |
| Drug | acetyl tert-butyl dimethylindan | 2.66e-05 | 2 | 118 | 2 | ctd:C033118 | |
| Drug | HO-PCB 104 | 2.66e-05 | 2 | 118 | 2 | CID000177870 | |
| Drug | 2-Chloroestradiol | 2.66e-05 | 2 | 118 | 2 | CID000067343 | |
| Drug | 4-chloroestradiol | 2.66e-05 | 2 | 118 | 2 | CID000067365 | |
| Drug | I 357 | 2.66e-05 | 2 | 118 | 2 | CID000007442 | |
| Drug | AC1L2X7C | 2.66e-05 | 2 | 118 | 2 | CID000104633 | |
| Drug | pyridate | 2.66e-05 | 2 | 118 | 2 | ctd:C043100 | |
| Drug | 5-acetyl-1,1,2,6-tetramethyl-3-isopropylindane | 2.66e-05 | 2 | 118 | 2 | ctd:C110695 | |
| Drug | tosyl azide | 2.66e-05 | 2 | 118 | 2 | CID000013661 | |
| Drug | bromoacetylcarnitine | 2.66e-05 | 2 | 118 | 2 | CID003080660 | |
| Drug | Melengestrol Acetate | 2.66e-05 | 2 | 118 | 2 | ctd:D008552 | |
| Drug | homosalate | 2.89e-05 | 12 | 118 | 3 | CID000008362 | |
| Drug | SbCl3 | 2.89e-05 | 12 | 118 | 3 | CID000024814 | |
| Drug | promegestone | 3.97e-05 | 37 | 118 | 4 | CID000036709 | |
| Drug | fulvestrant | 4.43e-05 | 484 | 118 | 11 | ctd:C070081 | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 5.51e-05 | 187 | 118 | 7 | 4364_UP | |
| Drug | Reductoleptomycin a | 5.99e-05 | 41 | 118 | 4 | CID006448769 | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 6.30e-05 | 191 | 118 | 7 | 2627_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; HL60; HT_HG-U133A | 6.51e-05 | 192 | 118 | 7 | 2580_UP | |
| Drug | oxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA | 6.73e-05 | 193 | 118 | 7 | 971_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A | 6.95e-05 | 194 | 118 | 7 | 2485_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 5728_DN | |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 4130_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 7259_UP | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 2786_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 7.90e-05 | 198 | 118 | 7 | 5416_UP | |
| Drug | 2-(((3,5-dichlorophenyl)carbamoyl)oxy)-2-methyl-3-butenoic acid | 7.96e-05 | 3 | 118 | 2 | ctd:C101851 | |
| Drug | DHTH | 7.96e-05 | 3 | 118 | 2 | CID000160230 | |
| Drug | Drospirenone | 7.96e-05 | 3 | 118 | 2 | DB01395 | |
| Drug | 2,4,6-trichlorophenyl-4'-aminophenyl ether | 7.96e-05 | 3 | 118 | 2 | ctd:C067259 | |
| Drug | Fludrocortisone | 7.96e-05 | 3 | 118 | 2 | DB00687 | |
| Drug | Nafoxidine | 7.96e-05 | 3 | 118 | 2 | ctd:D009256 | |
| Drug | mexrenone | 7.96e-05 | 3 | 118 | 2 | CID003082529 | |
| Drug | p-tert-amylphenol | 7.96e-05 | 3 | 118 | 2 | ctd:C019566 | |
| Drug | Benzophenones | 7.96e-05 | 3 | 118 | 2 | ctd:D001577 | |
| Drug | Chromans | 7.96e-05 | 3 | 118 | 2 | ctd:D002839 | |
| Drug | 4-hydroxybenzophenone | 7.96e-05 | 3 | 118 | 2 | ctd:C024292 | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; PC3; HT_HG-U133A | 8.15e-05 | 199 | 118 | 7 | 4677_DN | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.15e-05 | 199 | 118 | 7 | 3485_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 8.41e-05 | 200 | 118 | 7 | 3322_UP | |
| Drug | cyclopamine | 9.46e-05 | 46 | 118 | 4 | ctd:C000541 | |
| Drug | kenpaullone | 1.12e-04 | 48 | 118 | 4 | ctd:C119620 | |
| Drug | Mecam | 1.21e-04 | 49 | 118 | 4 | CID000194301 | |
| Drug | CV-1 | 1.25e-04 | 213 | 118 | 7 | CID000130105 | |
| Drug | di-n-pentyl phthalate | 1.42e-04 | 51 | 118 | 4 | ctd:C034171 | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.43e-04 | 152 | 118 | 6 | 6823_UP | |
| Drug | 9,10-dihydrophenanthrene | 1.59e-04 | 4 | 118 | 2 | CID000013058 | |
| Drug | laurolactam | 1.59e-04 | 4 | 118 | 2 | ctd:C474694 | |
| Drug | chloropropylate | 1.59e-04 | 4 | 118 | 2 | ctd:C004663 | |
| Drug | 4,4'-dihydroxybiphenyl | 1.59e-04 | 4 | 118 | 2 | ctd:C027439 | |
| Drug | Levonorgestrel | 1.59e-04 | 4 | 118 | 2 | DB00367 | |
| Drug | Progesterone | 1.59e-04 | 4 | 118 | 2 | DB00396 | |
| Drug | 11-ketotestosterone | 1.59e-04 | 4 | 118 | 2 | ctd:C003600 | |
| Drug | 1,4-diaminocyclohexane | 1.59e-04 | 4 | 118 | 2 | ctd:C088969 | |
| Drug | Fluoxymesterone | 1.59e-04 | 4 | 118 | 2 | DB01185 | |
| Drug | 2-sec-butylphenol | 1.59e-04 | 4 | 118 | 2 | ctd:C033932 | |
| Drug | isobutyl-4-hydroxybenzoate | 1.59e-04 | 4 | 118 | 2 | ctd:C045922 | |
| Drug | JK184 | 1.59e-04 | 4 | 118 | 2 | ctd:C525593 | |
| Drug | ethyl bromophos | 1.59e-04 | 4 | 118 | 2 | ctd:C041062 | |
| Drug | taleranol | 1.59e-04 | 4 | 118 | 2 | ctd:C028226 | |
| Drug | Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester | 1.59e-04 | 4 | 118 | 2 | ctd:D004849 | |
| Drug | AC1L1FBN | 1.59e-04 | 4 | 118 | 2 | CID000003167 | |
| Drug | phantolid | 1.59e-04 | 4 | 118 | 2 | ctd:C033117 | |
| Drug | SANT-1 compound | 1.59e-04 | 4 | 118 | 2 | ctd:C468919 | |
| Drug | 4-(heptyloxy)phenol | 1.59e-04 | 4 | 118 | 2 | ctd:C527833 | |
| Drug | isofenphos | 1.59e-04 | 4 | 118 | 2 | ctd:C035019 | |
| Drug | ciclesonide | 1.59e-04 | 4 | 118 | 2 | ctd:C120481 | |
| Drug | dichlofenthion | 1.59e-04 | 4 | 118 | 2 | ctd:C011445 | |
| Drug | mono-(2-ethylhexyl)phthalate | ABCA4 ESR1 INSR CHAT NR4A1 AR EGR1 KCNK6 NR5A1 MYO15A AJUBA PCOLCE | 1.61e-04 | 658 | 118 | 12 | ctd:C016599 |
| Drug | NSC89175 | 1.65e-04 | 53 | 118 | 4 | CID000098206 | |
| Drug | AC1L9K70 | 1.89e-04 | 228 | 118 | 7 | CID000446871 | |
| Drug | Bucladesine | 1.98e-04 | 306 | 118 | 8 | ctd:D003994 | |
| Drug | nitrofen | 2.40e-04 | 237 | 118 | 7 | ctd:C007350 | |
| Drug | GS-Hna | 2.54e-04 | 24 | 118 | 3 | CID000444455 | |
| Drug | 15d-PGJ2; Up 200; 10uM; HL60; HT_HG-U133A | 2.54e-04 | 169 | 118 | 6 | 2691_UP | |
| Drug | 2'-hydroxyflavone | 2.64e-04 | 5 | 118 | 2 | CID000161860 | |
| Drug | chlorobenzilate | 2.64e-04 | 5 | 118 | 2 | ctd:C004659 | |
| Drug | tolclofos-methyl | 2.64e-04 | 5 | 118 | 2 | ctd:C426783 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 5.15e-06 | 9 | 118 | 3 | DOID:0050338 (implicated_via_orthology) | |
| Disease | testosterone measurement | ZNF703 ESR1 INSR ARID1A CSMD3 MIDEAS AR REXO1 FZD7 SHROOM4 EGR1 LHFPL2 ZFHX3 PRRT1 MYO15A FKBP4 RAI1 | 1.30e-05 | 1275 | 118 | 17 | EFO_0004908 |
| Disease | myotonic dystrophy type 1 (is_marker_for) | 1.59e-05 | 2 | 118 | 2 | DOID:11722 (is_marker_for) | |
| Disease | congenital myopathy (implicated_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:0081337 (implicated_via_orthology) | |
| Disease | androgen insensitivity syndrome (implicated_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:4674 (implicated_via_orthology) | |
| Disease | Neoplasm of the genitourinary tract | 1.19e-04 | 24 | 118 | 3 | cv:C0042065 | |
| Disease | anti-human herpes virus 7 antibody measurement | 1.57e-04 | 5 | 118 | 2 | EFO_0011038 | |
| Disease | prostatic hypertrophy (implicated_via_orthology) | 2.35e-04 | 6 | 118 | 2 | DOID:11132 (implicated_via_orthology) | |
| Disease | MiT family translocation renal cell carcinoma | 3.29e-04 | 7 | 118 | 2 | C4518356 | |
| Disease | Malignant neoplasm of breast | ABCA4 ESR1 PER1 ARID1A AR CIC ARAP3 TRMT2A STPG1 GLI1 PRRT1 HOXB13 HNRNPR | 3.72e-04 | 1074 | 118 | 13 | C0006142 |
| Disease | prostate cancer (is_marker_for) | 4.19e-04 | 156 | 118 | 5 | DOID:10283 (is_marker_for) | |
| Disease | neuroticism measurement, cognitive function measurement | 4.63e-04 | 566 | 118 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Malignant tumor of prostate | 5.60e-04 | 9 | 118 | 2 | cv:C0376358 | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 6.99e-04 | 10 | 118 | 2 | EFO_0008200 | |
| Disease | granulocyte percentage of myeloid white cells | 7.48e-04 | 268 | 118 | 6 | EFO_0007997 | |
| Disease | Acute Promyelocytic Leukemia | 8.35e-04 | 46 | 118 | 3 | C0023487 | |
| Disease | Prostatic Neoplasms | 8.46e-04 | 616 | 118 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.46e-04 | 616 | 118 | 9 | C0376358 | |
| Disease | aortic valve stenosis (is_marker_for) | 8.52e-04 | 11 | 118 | 2 | DOID:1712 (is_marker_for) | |
| Disease | Prostatic Intraepithelial Neoplasias | 8.52e-04 | 11 | 118 | 2 | C0282612 | |
| Disease | breast cancer (is_marker_for) | 9.06e-04 | 185 | 118 | 5 | DOID:1612 (is_marker_for) | |
| Disease | mean arterial pressure | 9.13e-04 | 499 | 118 | 8 | EFO_0006340 | |
| Disease | Male sterility | 9.46e-04 | 48 | 118 | 3 | C0917731 | |
| Disease | Male infertility | 9.46e-04 | 48 | 118 | 3 | C0021364 | |
| Disease | Subfertility, Male | 9.46e-04 | 48 | 118 | 3 | C0848676 | |
| Disease | Liver carcinoma | 1.01e-03 | 507 | 118 | 8 | C2239176 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 1.02e-03 | 12 | 118 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | Neurodegeneration with brain iron accumulation | 1.20e-03 | 13 | 118 | 2 | cv:C2931845 | |
| Disease | nodular sclerosis Hodgkin lymphoma | 1.40e-03 | 14 | 118 | 2 | EFO_0004708 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 1.40e-03 | 14 | 118 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | leukemia | 1.41e-03 | 55 | 118 | 3 | C0023418 | |
| Disease | hypertension | 1.50e-03 | 307 | 118 | 6 | EFO_0000537 | |
| Disease | Endometrial Neoplasms | 1.64e-03 | 58 | 118 | 3 | C0014170 | |
| Disease | Insulin Resistance | 1.81e-03 | 60 | 118 | 3 | C0021655 | |
| Disease | polycystic ovary syndrome | 1.81e-03 | 60 | 118 | 3 | EFO_0000660 | |
| Disease | Insulin Sensitivity | 1.81e-03 | 60 | 118 | 3 | C0920563 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.04e-03 | 133 | 118 | 4 | EFO_0010092 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.07e-03 | 17 | 118 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | phosphatidylcholine 40:6 measurement | 2.07e-03 | 17 | 118 | 2 | EFO_0010389 | |
| Disease | Female Urogenital Diseases | 2.33e-03 | 18 | 118 | 2 | C1720887 | |
| Disease | chronic kidney disease | 2.59e-03 | 235 | 118 | 5 | EFO_0003884 | |
| Disease | X-24309 measurement | 2.87e-03 | 20 | 118 | 2 | EFO_0800872 | |
| Disease | Major Depressive Disorder | 2.99e-03 | 243 | 118 | 5 | C1269683 | |
| Disease | Endometrial Carcinoma | 3.04e-03 | 72 | 118 | 3 | C0476089 | |
| Disease | prostate carcinoma | UBAP2 PPP1R13B AR NLGN3 STPG1 ZFHX3 HOXB13 CRTC2 MOCOS DNAH11 | 3.11e-03 | 891 | 118 | 10 | EFO_0001663 |
| Disease | ectonucleoside triphosphate diphosphohydrolase 5 measurement | 3.17e-03 | 21 | 118 | 2 | EFO_0008115 | |
| Disease | pulse pressure measurement | ESR1 INSR FIGN CRIP3 HOXB3 HOXD3 NFATC2 DPF3 LPP LHFPL2 ZFHX3 COASY FOXD1 | 3.81e-03 | 1392 | 118 | 13 | EFO_0005763 |
| Disease | free androgen index | 4.00e-03 | 374 | 118 | 6 | EFO_0007005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGPTYPPGPGANTAS | 136 | O95429 | |
| PPGPGANTASYSGAY | 141 | O95429 | |
| LGLGPAYGSLQNPYG | 1406 | O60241 | |
| PGCLYYGVQPVGTPG | 201 | Q8WWN8 | |
| GTIESPGFPHGYPNY | 41 | Q96PZ7 | |
| GTILSPGYPEPYGNN | 1811 | Q96PZ7 | |
| IESPGFPYGYPNGAN | 76 | Q7Z407 | |
| GAAYRYPPGVVGVAP | 376 | Q13363 | |
| APGQGPYPYSLSEPA | 36 | Q5T035 | |
| ALGPGIYSSPGSYDP | 101 | Q15744 | |
| YLDQVFPGDYGTPLP | 856 | P78363 | |
| APAGYSPGGVPSAYP | 191 | Q96IF1 | |
| YEQAAGYPFSAGLPP | 341 | Q8NFJ8 | |
| PGPAYSGREIIYPNA | 91 | P06731 | |
| RGPGLAPGQIYTYPA | 61 | Q92782 | |
| GPFPPYASGTGYVLS | 256 | O96024 | |
| LAPGFAAPPYLDYAG | 4176 | Q96DT5 | |
| FGPVVPDGYGVCYNP | 566 | P43155 | |
| GFSGYPQPPSQSYGG | 101 | P20073 | |
| IPGVGKQLPPSYGTY | 451 | Q96KQ4 | |
| GSAGHPPDAQPGLYY | 291 | Q76LX8 | |
| AFPGYGVQDSSPYPG | 96 | Q7Z5J4 | |
| GYVASEGFPNLYPPN | 46 | Q15113 | |
| PTAIPAYPGVVYQDG | 301 | O43251 | |
| CGYGLQLPPYAPPSA | 276 | Q16676 | |
| GPVGPPNYSEGTLPY | 736 | Q9Y5F8 | |
| GLGDYVPGEAPGQPY | 216 | Q9Y257 | |
| TLPYYQPIPGGLNVG | 16 | P56470 | |
| FQVYGCYPGPLSGPV | 106 | P22736 | |
| PAYGFGQPYGRSPSA | 146 | O14497 | |
| PASYADGVYQPLGEP | 56 | Q9NRD9 | |
| SPTHGGLGSQPYYPQ | 696 | Q13469 | |
| PIYPPGSTVLVEGGY | 96 | Q15038 | |
| PPTTVPGYTYQGHGL | 286 | Q5HY92 | |
| PGYTYQGHGLTPIAP | 291 | Q5HY92 | |
| CNGYPQPYLGSPVSL | 61 | P31275 | |
| YYSLSGILGPPVPGF | 466 | P08235 | |
| NAYPSPLGYGGFPKS | 136 | Q6UB28 | |
| GTYDGNFYGTPKPPA | 181 | Q5TCQ9 | |
| APNYNPAPSVAYSGG | 466 | O75112 | |
| AVGEGYPGPTVFPDY | 436 | Q2M2H8 | |
| EQEPYLAGLGPYSPA | 256 | Q9UKN7 | |
| HRGPGLAPGQLYTYP | 61 | Q92784 | |
| AGPQPGSYEIRHYGP | 31 | Q9Y5Z4 | |
| LEPGYPQPLTSYGLG | 446 | P51511 | |
| SATGAYPATGPYGAP | 96 | P17931 | |
| YPATGPYGAPAGPLI | 101 | P17931 | |
| PYGAPAGPLIVPYNL | 106 | P17931 | |
| PGSAGTALQYPPPAY | 226 | P18146 | |
| QRKYGGPPPDSVYSG | 141 | O60506 | |
| PSSYPYGALQTPAEG | 931 | O15534 | |
| QVYGQTGLPYGPGSE | 71 | P03372 | |
| GPGVLPNYSEGTLPY | 736 | Q9Y5G2 | |
| KYGGPPPDSVYSGVQ | 146 | O43390 | |
| LQPEPGYGYAPNQGR | 281 | Q93052 | |
| GGSPEPYHPTLGIYA | 51 | Q6ZUX7 | |
| ANPLGLPYYNGVGTV | 206 | P50458 | |
| PPTVAGGGQNFDPYL | 666 | P08151 | |
| QKPAFGQYPGYSPQG | 1176 | P10070 | |
| GQYPGYSPQGLQASP | 1181 | P10070 | |
| PSAPRLAYGYGPGSL | 21 | Q96EN8 | |
| GAVAPYGYTRPPQGL | 476 | P10275 | |
| GAPGQGPYPYSLSEP | 386 | Q9NZB2 | |
| GGVYLPPAADLPYGL | 61 | P31260 | |
| GPLGPLYASSNPEYL | 986 | P06213 | |
| AYSGQLPPVPGLAYD | 281 | P31249 | |
| GGYPQCAPAVYSGNL | 121 | P49639 | |
| YPGPPNSGGQYGSGL | 26 | Q9UBV8 | |
| YGQGGAPPNVDPEAY | 106 | Q9UBV8 | |
| VDQYLGVPYAAPPIG | 66 | Q9NZ94 | |
| GPGGGPTAYPTAPYL | 171 | O75084 | |
| GGQPPGRQSHYGTPY | 521 | Q53ET0 | |
| LAYVATPQNPGYLGP | 141 | Q9BUX1 | |
| VYVGGGGYADPLPPP | 351 | P14651 | |
| QLTSPGYPEPYGKGQ | 51 | Q9NZP8 | |
| GDYTLYSPPPPAGGA | 276 | P36269 | |
| GVNIGGVGSYLYNPP | 66 | Q6Q6R5 | |
| GVGSYLYNPPTPSPG | 71 | Q6Q6R5 | |
| KGSPHPGVGVPTYYN | 146 | Q6PJG2 | |
| GGGPGQYPHLAPTYA | 141 | P49356 | |
| PAGGYAAQPGYGALP | 206 | A6NMB9 | |
| PGAGSGVPYFYLSPL | 96 | O75629 | |
| YAYGSAGSPPKIPPN | 111 | Q02790 | |
| QGTSPAPVPYGYFGG | 71 | Q92826 | |
| GTLPLGGYVAPGYPL | 156 | Q99946 | |
| GGYVAPGYPLQLQPC | 161 | Q99946 | |
| VYPVGTPYAGGTPGG | 181 | Q99946 | |
| APAIPYGAYNGPVPG | 36 | P53992 | |
| SGLYGSYPQGQAPPL | 176 | P53992 | |
| FGPARGPQSNYGGPY | 286 | P53992 | |
| GPQSNYGGPYPAAPT | 291 | P53992 | |
| IPGPGQYDSPDANTY | 201 | Q3SX64 | |
| NGAYPALGPGVTANP | 126 | Q8IVF1 | |
| GEAPPAAGLGYDPYN | 46 | Q8N1G1 | |
| PYSSASPGNYVGPPG | 231 | P81877 | |
| YGYPEPFSGGPNVPE | 211 | Q13285 | |
| TGPGPQPGLYSYIRD | 51 | Q8IZ69 | |
| YGVSAPGPGYAPLRE | 251 | Q7Z736 | |
| GAYPPGTQVVYAANG | 151 | Q96CS7 | |
| GGYYPAQDPALVPPQ | 366 | Q92733 | |
| EEGAPVFPLGYQYPS | 106 | Q9UN36 | |
| QPEQAQPPCYYGIGG | 1226 | Q9ULL8 | |
| PLPPNYSYGLCPGNG | 216 | Q8NBI5 | |
| DGTYYLPVSGTPNPA | 976 | E7EW31 | |
| YVATPPYSQPQPGIG | 6 | O94855 | |
| YQPPPLPGQTLGAGY | 206 | O94855 | |
| YSGPKPSTQYGAPGP | 386 | Q96RK0 | |
| SVAVPPQAPFGYGYT | 1646 | Q00610 | |
| GPVVPNGYGACYNPQ | 671 | P28329 | |
| YAPGGPAYQPVVEAF | 396 | Q13057 | |
| EVCPPPGYGLDGLQY | 416 | Q9Y6X2 | |
| PGYGLDGLQYSPVQG | 421 | Q9Y6X2 | |
| FVNPALPPGYSYTGL | 901 | Q5T6F2 | |
| GPSLKAGGYPLVYPG | 406 | Q9H7S9 | |
| SYAGGRPPSYAGSPV | 331 | Q9C0H9 | |
| LYGDGYGFRLPPSSP | 461 | Q9C0H9 | |
| FPGPGQYEIVDYLGP | 266 | Q5TH74 | |
| YHQSKGPGAPQYPAG | 141 | Q99619 | |
| AGGVLYQPSGPASFP | 576 | O14964 | |
| SVIVYGAPPAGYGAP | 171 | Q6ICG8 | |
| YGAQPVGNEGPPVGY | 196 | Q6ICG8 | |
| LGYGAPPLGYGTPPL | 236 | Q6ICG8 | |
| GSQVYAGPPPSGAYL | 401 | Q92783 | |
| AGPPPSGAYLVAGNA | 406 | Q92783 | |
| PKDGTPAPGYPSYQQ | 156 | O60830 | |
| IYIYNGPVLGGPPGP | 361 | P36941 | |
| GVYFGNPYPFGIDPI | 511 | Q9HBG4 | |
| GYPLIPGQYDPFQGL | 1471 | Q9ULD9 | |
| RTAPPAAPLAGLYYG | 271 | P35713 | |
| LPGAPGSGYVNPAYV | 311 | Q6UXY8 | |
| AYGSELYGPGRPLSP | 491 | A7MCY6 | |
| FYSGPLGPTYPAAQL | 236 | A5D8V6 | |
| VFGINPGVAPPAGAY | 856 | Q08AF3 | |
| PPGAGTYPTLQPFQY | 436 | Q8WY91 | |
| FLGAYAYPPRPQAAG | 71 | Q9UL17 | |
| PCGVPNGGYYRPEGT | 601 | Q63HR2 | |
| LYQGYGSTVPLGQPG | 11 | A6NP61 | |
| SPYYAPQIPGALQSG | 3316 | Q15911 | |
| QGGPDVVQPYAAYAP | 141 | Q9UQQ1 | |
| EPPAYDGGSPILGYF | 641 | Q00872 |